1. Home
  2. IDE vs NBTX Comparison

IDE vs NBTX Comparison

Compare IDE & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IDE
  • NBTX
  • Stock Information
  • Founded
  • IDE 2010
  • NBTX 2003
  • Country
  • IDE United States
  • NBTX France
  • Employees
  • IDE N/A
  • NBTX N/A
  • Industry
  • IDE Finance/Investors Services
  • NBTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • IDE Finance
  • NBTX Health Care
  • Exchange
  • IDE Nasdaq
  • NBTX Nasdaq
  • Market Cap
  • IDE 172.8M
  • NBTX 167.8M
  • IPO Year
  • IDE N/A
  • NBTX 2020
  • Fundamental
  • Price
  • IDE $11.38
  • NBTX $4.48
  • Analyst Decision
  • IDE
  • NBTX Strong Buy
  • Analyst Count
  • IDE 0
  • NBTX 1
  • Target Price
  • IDE N/A
  • NBTX $8.00
  • AVG Volume (30 Days)
  • IDE 33.5K
  • NBTX 9.0K
  • Earning Date
  • IDE 01-01-0001
  • NBTX 04-02-2025
  • Dividend Yield
  • IDE 8.83%
  • NBTX N/A
  • EPS Growth
  • IDE N/A
  • NBTX N/A
  • EPS
  • IDE N/A
  • NBTX N/A
  • Revenue
  • IDE N/A
  • NBTX N/A
  • Revenue This Year
  • IDE N/A
  • NBTX N/A
  • Revenue Next Year
  • IDE N/A
  • NBTX $221.06
  • P/E Ratio
  • IDE N/A
  • NBTX N/A
  • Revenue Growth
  • IDE N/A
  • NBTX N/A
  • 52 Week Low
  • IDE $8.61
  • NBTX $2.76
  • 52 Week High
  • IDE $10.46
  • NBTX $6.00
  • Technical
  • Relative Strength Index (RSI)
  • IDE 60.83
  • NBTX 51.68
  • Support Level
  • IDE $11.36
  • NBTX $4.18
  • Resistance Level
  • IDE $11.48
  • NBTX $5.76
  • Average True Range (ATR)
  • IDE 0.07
  • NBTX 0.24
  • MACD
  • IDE -0.03
  • NBTX -0.06
  • Stochastic Oscillator
  • IDE 60.71
  • NBTX 21.69

About IDE Voya Infrastructure Industrials and Materials Fund of Beneficial Interest

Voya Infrastructure, Industrials and Materials Fund is a diversified closed-end management investment company. The primary objective of this investment fund is to achieve total return by combining current income, capital gains, and capital appreciation. To achieve this objective, the fund invests in companies that own and/or operate infrastructure facilities in the infrastructure sector, as well as in a broad range of companies in the industrials and materials sectors that the Sub-Adviser believes will benefit from infrastructure building, renovation, expansion, and utilization.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Share on Social Networks: